Differentiating Tumor-stroma Ratio in Pancreatic Ductal Adenocarcinoma

Active, not recruitingOBSERVATIONAL

Enrollment

207

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

July 31, 2022

Study Completion Date

March 31, 2024

Conditions

Pancreatic Ductal Adenocarcinoma

All Listed Sponsors

lead

First Affiliated Hospital of Chongqing Medical University

OTHER

NCT06302881 - Differentiating Tumor-stroma Ratio in Pancreatic Ductal Adenocarcinoma | Biotech Hunter | Biotech Hunter